Metraipolis › archive › dc_899f38fc830c

Incorporating mRNA therapeutics into biological treatments of hematologic malignancies — Europe PMC PMID:41200165

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41200165
DOI: 10.3389/fimmu.2025.1680071
License (as archived): solo-consultazione
Archived: 2026-11-09T03:40:30.078Z
SHA-256 of the archived text: e5ab7552824ed0093a0ff509582c74abe276e65d79aa5afed8f88e9884c500e3
Stable URL of this page: https://metraipolis.com/documento/dc_899f38fc830c

How to cite

Incorporating mRNA therapeutics into biological treatments of hematologic malignancies — Europe PMC PMID:41200165 — Europe PMC (en), https://europepmc.org/article/MED/41200165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_899f38fc830c (Metraipolis archive dc_899f38fc830c, sha256 e5ab7552824ed0093a0ff509582c74abe276e65d79aa5afed8f88e9884c500e3)

BibTeX

@misc{dc899f38fc830c,
  title = {Incorporating mRNA therapeutics into biological treatments of hematologic malignancies — Europe PMC PMID:41200165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41200165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_899f38fc830c; sha256 e5ab7552824ed0093a0ff509582c74abe276e65d79aa5afed8f88e9884c500e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41200165. Agents can read the archived copy with the MCP tool read_document.